BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 31391252)

  • 1. The subcellular localization of type I p21-activated kinases is controlled by the disordered variable region and polybasic sequences.
    Sun X; Su VL; Calderwood DA
    J Biol Chem; 2019 Sep; 294(39):14319-14332. PubMed ID: 31391252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAK6 targets to cell-cell adhesions through its N-terminus in a Cdc42-dependent manner to drive epithelial colony escape.
    Morse EM; Sun X; Olberding JR; Ha BH; Boggon TJ; Calderwood DA
    J Cell Sci; 2016 Jan; 129(2):380-93. PubMed ID: 26598554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mutations in the Effector Domain of RhoV GTPase Impair Its Binding to Pak1 Protein Kinase].
    Korobko IV; Shepelev MV
    Mol Biol (Mosk); 2018; 52(4):692-698. PubMed ID: 30113035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an autoinhibitory domain of p21-activated protein kinase 5.
    Ching YP; Leong VY; Wong CM; Kung HF
    J Biol Chem; 2003 Sep; 278(36):33621-4. PubMed ID: 12860998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDC42 binds PAK4 via an extended GTPase-effector interface.
    Ha BH; Boggon TJ
    Proc Natl Acad Sci U S A; 2018 Jan; 115(3):531-536. PubMed ID: 29295922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophosphorylation-dependent degradation of Pak1, triggered by the Rho-family GTPase, Chp.
    Weisz Hubsman M; Volinsky N; Manser E; Yablonski D; Aronheim A
    Biochem J; 2007 Jun; 404(3):487-97. PubMed ID: 17355222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.
    McCarty SK; Saji M; Zhang X; Jarjoura D; Fusco A; Vasko VV; Ringel MD
    Endocr Relat Cancer; 2010 Dec; 17(4):989-99. PubMed ID: 20817787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p21-activated kinases: three more join the Pak.
    Jaffer ZM; Chernoff J
    Int J Biochem Cell Biol; 2002 Jul; 34(7):713-7. PubMed ID: 11950587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling, Regulation, and Specificity of the Type II p21-activated Kinases.
    Ha BH; Morse EM; Turk BE; Boggon TJ
    J Biol Chem; 2015 May; 290(21):12975-83. PubMed ID: 25855792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of small GTPase signaling pathways using p21-activated kinase mutants that selectively couple to Cdc42.
    Reeder MK; Serebriiskii IG; Golemis EA; Chernoff J
    J Biol Chem; 2001 Nov; 276(44):40606-13. PubMed ID: 11514549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity profiling of Pak kinases allows identification of novel phosphorylation sites.
    Rennefahrt UE; Deacon SW; Parker SA; Devarajan K; Beeser A; Chernoff J; Knapp S; Turk BE; Peterson JR
    J Biol Chem; 2007 May; 282(21):15667-78. PubMed ID: 17392278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAK signaling in cancer.
    Ye DZ; Field J
    Cell Logist; 2012 Apr; 2(2):105-116. PubMed ID: 23162742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a novel mechanism of the PAK1 interaction with the Rho-GTPases Cdc42 and Rac.
    Shin YJ; Kim EH; Roy A; Kim JH
    PLoS One; 2013; 8(8):e71495. PubMed ID: 23936510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group I and II mammalian PAKs have different modes of activation by Cdc42.
    Baskaran Y; Ng YW; Selamat W; Ling FT; Manser E
    EMBO Rep; 2012 Jun; 13(7):653-9. PubMed ID: 22653441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of p21-activated kinase 6 by MAP kinase kinase 6 and p38 MAP kinase.
    Kaur R; Liu X; Gjoerup O; Zhang A; Yuan X; Balk SP; Schneider MC; Lu ML
    J Biol Chem; 2005 Feb; 280(5):3323-30. PubMed ID: 15550393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAK1 and PAK2 have different roles in HGF-induced morphological responses.
    Bright MD; Garner AP; Ridley AJ
    Cell Signal; 2009 Dec; 21(12):1738-47. PubMed ID: 19628037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecules that allosterically inhibit p21-activated kinase activity by binding to the regulatory p21-binding domain.
    Kim DJ; Choi CK; Lee CS; Park MH; Tian X; Kim ND; Lee KI; Choi JK; Ahn JH; Shin EY; Shin I; Kim EG
    Exp Mol Med; 2016 Apr; 48(4):e229. PubMed ID: 27126178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the p21-activated kinase (PAK) by a human Gbeta -like WD-repeat protein, hPIP1.
    Xia C; Ma W; Stafford LJ; Marcus S; Xiong WC; Liu M
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6174-9. PubMed ID: 11371639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AR and ER interaction with a p21-activated kinase (PAK6).
    Lee SR; Ramos SM; Ko A; Masiello D; Swanson KD; Lu ML; Balk SP
    Mol Endocrinol; 2002 Jan; 16(1):85-99. PubMed ID: 11773441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho family GTPase signaling through type II p21-activated kinases.
    Chetty AK; Ha BH; Boggon TJ
    Cell Mol Life Sci; 2022 Nov; 79(12):598. PubMed ID: 36401658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.